ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Effect of immunosuppressive agents on vaccine immunogenicity

Effect of immunosuppressive agents on vaccine immunogenicity
  Methotrexate TNF-alpha inhibitors Anti-CD20 antibodies
(eg, rituximab)
CTLA-4 inhibitors
(eg, abatacept)
Janus kinase inhibitors
(eg, tofacitinib)
Anti-IL-6 antibodies
(eg, tocilizumab)
Pneumococcal vaccine Decrease Minimal effect Substantial decrease Decrease Decrease Minimal effect
Seasonal influenza vaccine Probable decrease Minimal effect Substantial decrease Decrease Minimal effect Minimal effect
Hepatitis B virus vaccine Unknown Decrease Unknown Unknown Unknown Unknown
For most patients with autoimmune inflammatory rheumatic disease using conventional synthetic disease-modifying antirheumatic drugs, most biologics, or glucocorticoids, vaccinations are expected to confer adequate protection, although the immune response to some vaccines may be blunted. The degree to which the immune response may be altered by these medications varies based on the specific immunosuppressive drug regimen, vaccines used, and other patient-specific factors. The effect of immunosuppressive agents on the immune responses to vaccines other than those listed above has not been well studied. Refer to the UpToDate text for additional detail.
TNF: tumor necrosis factor; CTLA: cytotoxic T lymphocyte antigen; IL: interleukin.
Data from:
  1. Subesinghe S, Bechman K, Rutherford AI, et al. A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis. J Rheumatol 2018; 45:733.
  2. Friedman MA, Winthrop K. Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol 2016; 28:330.
Graphic 119666 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟